Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00204854
Other study ID # 1999-514
Secondary ID 1R01AA012826
Status Completed
Phase Phase 3
First received September 12, 2005
Last updated October 1, 2015
Start date December 2001
Est. completion date November 2004

Study information

Verified date January 2011
Source University of Wisconsin, Madison
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

Randomized controlled trial and benefit-cost study of a telephone and mail intervention for non-treatment-seeking primary care patients with alcohol abuse or dependence


Recruitment information / eligibility

Status Completed
Enrollment 900
Est. completion date November 2004
Est. primary completion date June 2004
Accepts healthy volunteers No
Gender Both
Age group 21 Years to 59 Years
Eligibility Inclusion Criteria:

- primary care patients with DSM-IV alcohol abuse or dependence

Exclusion Criteria:

- pregnancy

- suicidality

- alcohol treatment in prior 3 months

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind


Related Conditions & MeSH terms


Intervention

Behavioral:
telephone counseling


Locations

Country Name City State
United States University of Wisconsin Madison Wisconsin

Sponsors (3)

Lead Sponsor Collaborator
University of Wisconsin, Madison National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Self-reported alcohol consumption in the prior 28 days
Primary Number of risky drinking days in the prior 28 days
Secondary Health care utilization
Secondary car crashes
Secondary criminal justice system involvement
See also
  Status Clinical Trial Phase
Completed NCT02179749 - Mifepristone Treatment of Alcohol Use Disorder Phase 2
Completed NCT02113618 - Effect of Cognitive Training on Alcohol Use Outcomes N/A
Completed NCT01008280 - Baclofen to Reduce Alcohol Use in Veterans With HCV Phase 4
Active, not recruiting NCT02671019 - Effectiveness and Costs of Internet-based Treatment for Harmful Alcohol Use and Face-to-face Treatment in Addiction Care N/A
Completed NCT01751035 - Integrative Risk Reduction and Treatment for Teen Substance Use Problems and PTSD N/A
Active, not recruiting NCT03695653 - Messaging Interventions to Reduce Alcohol Problems Project N/A
Completed NCT02298751 - Exposure Therapy as Aftercare for Alcohol Use Disorder N/A
Completed NCT01642381 - Component Analysis for Motivational Interviewing N/A
Terminated NCT01566370 - Zonisamide for Heavy Drinkers With Bipolar Disorder Phase 2
Completed NCT02511808 - Adaptive Interventions for Problem Drinkers N/A
Completed NCT02384278 - Internet Based Cognitive Behavior Treatment for Alcohol Problems N/A
Completed NCT01613014 - ABT-436 for Alcohol Dependence Phase 2
Completed NCT02905162 - Understanding Longitudinal Clinical Outcomes and Post-release Retention in Care Among HIV-infected Prisoners in Lusaka, Zambia
Completed NCT02808468 - Brief Restructuring Intervention Following Trauma Exposure N/A
Completed NCT01692054 - Risk and Protective Factors of Children and Adolescents Who Were Hospitalized Due to Alcohol Intoxication N/A
Completed NCT02500602 - CAP: Doxazosin in the Treatment of Co-Occurring PTSD and Alcohol Use Disorders Phase 2
Active, not recruiting NCT02713217 - Implementing a Blended Care Model That Integrates Mental Healthcare and Primary Care Using Telemedicine and Care Management for Patients With Depression or Alcohol Use Disorder in Small Primary Care Clinics
Recruiting NCT02465177 - Tailoring Screening, Brief Intervention, and Referral to Treatment for Medical ICU Survivors
Completed NCT02193256 - Varenicline + Prazosin for Heavy Drinking Smokers Early Phase 1
Completed NCT01172210 - Examining Common Substrates of Eating and Alcohol Use Disorders N/A